Overviews and analysis of the U.S. FDA′s new approvals in 2014 first half year / 国际药学研究杂志
Journal of International Pharmaceutical Research
;
(6): 493-502, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-456269
ABSTRACT
In the first half of 2014, the U.S. Food and Drug Administration (FDA) approved 46 new drugs, including 10 new molecular entities and 10 new biologic license applications. According to the prescription information for professionals, this article introduces the description, mechanism of action and clinical studies, briefly describs the box warning, indications and usage, dosage and administration, dosage form and strength, contraindications, warning and precautions, adverse reactions, drug interaction and use in special population of these new drugs. In addition, the “first events” in the history of new drug research, development and approval are also discussed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Pharmaceutical Research
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS